28 programming-"the"-"DAAD"-"EURAXESS"-"IMPRS-ML"-"IMPRS-ML"-"Dr" Fellowship positions at UNIVERSITY OF SOUTHAMPTON
Sort by
Refine Your Search
-
We are seeking a highly motivated and skilled Research Fellow to join the Cancer Data-Driven Detection (CD3) programme. CD3 is a new, multidisciplinary and multi-institutional strategic national
-
. The successful candidate will work part time as clinical research fellow supporting Professor Clark in his NIHR funded research programme on rapid diagnostic tests. The University of Southampton, Faculty
-
The University of Southampton is inviting applications for a postdoctoral position in gravitational-wave astronomy. The successful candidate will join Greg Ashton’s STFC-funded programme, Advancing
-
(R3) Country United Kingdom Application Deadline 29 Sep 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU
-
Dec 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within
-
Application Deadline 27 Nov 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff
-
United Kingdom Application Deadline 15 Dec 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job
-
Application Deadline 13 Nov 2025 - 00:00 (UTC) Type of Contract Other Job Status Part-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff
-
Application Deadline 21 Nov 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff
-
the laboratory of Professors Ward and Ober. Their interdisciplinary research program is dedicated to the development of novel antibody-based therapeutics that has led to several therapeutics that are currently in